XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flows from Operating Activities:    
Net income (loss) $ 24,388,307 $ (2,304,562)
Adjustments to reconcile net income (loss) to net cash flows used in by operating activities:    
Depreciation and amortization 239,630 189,390
Gain on extinguishment of debt (10,000)
Stock based compensation 1,148,327 1,186,771
Change in fair value of warrant derivative liabilities (33,274,039)
Provision for inventory obsolescence 339,668 254,109
Amortization of discount on unsecured promissory notes 86,867
Change in fair value of short-term investments 28,210
Change in fair value of secured convertible notes 1,300,252
Change in fair value of proceeds investment agreement (5,250,000)
Provision for doubtful accounts receivable (527)
Issuance of common stock for services rendered 30,700
Debt issuance costs 34,906
(Increase) decrease in:    
Accounts receivable – trade 337,364 (728,917)
Accounts receivable – other 111,768 (370,123)
Inventories (1,767,724) (967,324)
Income tax refund receivable 44,650
Prepaid expenses (3,445,546) (1,914,855)
Operating lease right of use assets (27,875) (669,662)
Other assets (752,324) (110,679)
Increase (decrease) in:    
Accounts payable (475,256) (1,281,246)
Accrued expenses 209,833 (129,593)
Income taxes payable (5,331) (4,776)
Operating lease obligations 14,757 633,505
Contract liabilities 709,977 (145,018)
Net cash used in operating activities (12,230,781) (10,115,605)
Cash Flows from Investing Activities:    
Purchases of property, building and equipment (5,575,021) (599,449)
Additions to other intangible assets (239,139) (40,277)
Additions to investments (250,000)
Cash paid for Nobility Healthcare Division acquisition, net of cash acquired (1,012,552)
Cash paid for Nobility Healthcare Division acquisition, net of cash acquired (2,270,000)
Cash paid for TicketSmarter acquisition, net of cash acquired (8,361,808)
Restricted cash related to TicketSmarter acquisition (500,000)
Net cash used in investing activities (17,958,520) (889,726)
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock upon exercise of pre-funded warrants 53,224,000
Net proceeds from sale of common stock in registered direct offerings 13,346,600
Proceeds from unsecured promissory note payable, related party 319,000
Proceeds from unsecured promissory note payable 100,000
Proceeds from promissory notes payable 1,568,900
Proceeds from issuance of common stock upon exercise of warrants 5,203,122
Proceeds from issuance of secured convertible notes payable 1,500,000
Proceeds from sale of common stock in underwritten public offering 12,829,241
Proceeds from exercise of stock options 7,800
Principal payment on subordinated notes payable (400,000)
Principal payment on secured convertible notes (748,180)
Principal payments on unsecured promissory note payable, related party (319,000)
Debt issuance costs (34,906)
Principal payment on proceeds investment agreement (1,250,000)
 Net cash provided by financing activities 66,570,600 18,775,977
Net increase in cash and cash equivalents 36,381,299 7,770,646
Cash and cash equivalents, beginning of period 4,361,758 359,685
Cash and cash equivalents, end of period 40,743,057 8,130,331
Supplemental disclosures of cash flow information:    
Cash payments for interest 128,911
Cash payments for income taxes 7,581 4,776
Supplemental disclosures of non-cash investing and financing activities:    
Issuance of contingent consideration earn-out agreement for business acquisition 4,244,400
Issuance of contingent consideration promissory note for business acquisitions 1,000,000
Assets assumed in business acquisitions 7,366,399
Liabilities assumed in business acquisitions 5,494,417
Common stock issued as consideration for business acquisitions 990,360
Restricted common stock grant 856 845
Restricted common stock forfeitures 8 36
Cashless exercise of common stock purchase warrants 0 7
Amounts allocated to initial measurement of warrant derivative liabilities in connection to the warrants and pre-funded warrants 51,216,058
Issuance of common stock upon conversion of secured convertible notes 3,024,685
Amounts allocated to common stock purchase warrants in connection with issuance of unsecured promissory note payable $ 741,947